Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs Lakewood-Amedex Biotherapeutics Inc. (LABT)

Bone Biologics Corp. and Lakewood-Amedex Biotherapeutics Inc. are both Biotechnology companies. Lakewood-Amedex Biotherapeutics Inc. is the larger, with a market value of $1.3M against $1.1M — 1.2× the size. Across the 8 metrics below, Bone Biologics Corp. leads on 5 and Lakewood-Amedex Biotherapeutics Inc. on 3.

Valuation

Metric BBLG LABT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.20 0.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.71 0.66
EV/Sales n/m n/m 9.02
Earnings yield (438.22%) (2,135.14%) (32.88%)
Free cash flow yield (214.89%) (934.12%) (23.13%)

Profitability

Metric BBLG LABT Biotechnology median
Gross margin — — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.49%) 0.00% (51.96%)
Return on assets (44.46%) (302.50%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG LABT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 90.85% 15.32% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BBLG LABT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.38 7.70 4.97
Net debt to EBITDA 1.65 0.06 1.01

Dividend

Metric BBLG LABT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BBLG LABT Biotechnology median
Market cap 1.10m 1.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack